Stocks · Healthcare · Medical - Devices
Boston Scientific Corporation BSX
$42.60 -1.46% Close, Oct 2, 2026 · NYSE · Market cap $63.32B
Weak trendInexpensive vs sector
Next earnings report: Oct 28, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- At 17.3× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Earnings beat analyst estimates in each of the last 14 quarters (average surprise over the last four: +3.0%).
- Diluted EPS over the last four quarters was $2.46, up 46.7% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 42%
- EPS growth (TTM, YoY)Top 29%
- FCF growth (TTM, YoY)Top 49%
- Revenue growth, 3-year CAGRTop 37%
- Revenue growth accelerationBottom 28%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 13%
- Gross marginTop 41%
- Operating marginTop 12%
- Cash conversion (OCF / net income)Bottom 33%
- Accruals (lower is better)Bottom 23%
- Net debt / EBITDA (lower is better)Bottom 37%
- Interest coverTop 15%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 8%
- Free-cash-flow yieldTop 16%
- EBITDA / enterprise valueTop 15%
- Sales / enterprise valueTop 44%
- P/E vs own 5-year history (lower is better)Top 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 7%
- 6-month returnBottom 14%
- 1-year return vs S&P 500Bottom 8%
- Distance from 52-week highBottom 17%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 49%
- Consecutive EPS beatsTop 2%
- Share of analysts rating BuyTop 36%
- Upside to consensus price targetBottom 44%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 17%
- Maximum drawdown, 3 yearsTop 35%
- Beta vs S&P 500 (lower is better)Top 30%
- Net debt / EBITDA (lower is better)Bottom 37%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 17.4% | 13.5% | ↓ |
| EPS growth (YoY) | 74.4% | 46.7% | ↓ |
| Gross margin | 63.2% | 71.2% | ↑ |
| Operating margin | 16.1% | 21.5% | ↑ |
| FCF margin | 17.9% | 17.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 13.5% | 17.4% | ↓ | Top 42% |
| EPS growth (TTM, YoY) | 46.7% | 74.4% | ↓ | Top 29% |
| Gross margin | 71.2% | 63.2% | ↑ | Top 41% |
| Operating margin | 21.5% | 16.1% | ↑ | Top 12% |
| Net margin | 17.5% | 13.5% | ↑ | — |
| Free-cash-flow margin | 17.3% | 17.9% | ↓ | — |
| Return on invested capital | 10.6% | — | Top 13% | |
| Revenue growth, 3-year CAGR | 16.5% | — | Top 37% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.24×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -5.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 2.13×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 12.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 2.81%
- Shareholder yield
- 2.81%
- Share count change, 1 year
- -0.6%
- Share count change, 3-year CAGR
- +0.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 3, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 14
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +3.0%
- Average 2-day reaction, last 8
- +0.6%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $64.67
- Target vs current price
- +51.8%
- Analysts with a rating
- 44
- Share rating Buy or Strong Buy
- 84%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 29, 2026 | +3.0% | -0.0% | +6.6% | +8.3% | — |
| Apr 22, 2026 | +1.5% | +9.0% | -1.8% | -4.6% | -26.0% |
| Feb 4, 2026 | +2.4% | -17.6% | -19.0% | -21.2% | -37.1% |
| Oct 22, 2025 | +5.0% | +4.0% | +1.1% | -0.7% | -11.8% |
| Jul 23, 2025 | +3.4% | +4.5% | +3.2% | +0.6% | -5.3% |
| Apr 23, 2025 | +11.4% | +4.0% | +8.1% | +12.1% | +9.0% |
| Feb 5, 2025 | +6.5% | +1.4% | +2.4% | +1.1% | -0.3% |
| Oct 23, 2024 | +7.1% | -0.6% | -3.9% | +2.6% | +14.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 29, 2026 | $0.86 | $0.84 | +3.0% | $5.44B |
| Apr 22, 2026 | $0.80 | $0.79 | +1.5% | $5.20B |
| Feb 4, 2026 | $0.80 | $0.78 | +2.4% | $5.29B |
| Oct 22, 2025 | $0.75 | $0.71 | +5.0% | $5.07B |
| Jul 23, 2025 | $0.75 | $0.73 | +3.4% | $5.06B |
| Apr 23, 2025 | $0.75 | $0.67 | +11.4% | $4.66B |
| Feb 5, 2025 | $0.70 | $0.66 | +6.5% | $4.56B |
| Oct 23, 2024 | $0.63 | $0.59 | +7.1% | $4.21B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 17.3× | 63.7× | 0th | Top 8% |
| P/E (forward) | 13.0× | — | — | — |
| EV / EBITDA | 13.3× | — | — | Top 15% |
| EV / Sales | 3.59× | — | — | Top 44% |
| Free-cash-flow yield | 5.72% | — | — | Top 16% |
| Earnings yield | 5.77% | — | — | Top 8% |
P/E over the past five years
Range 19.7× – 137.0× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -55.6%
- Earnings per share growth (TTM)
- +46.7%
- Change in P/E multiple
- -68.7%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +0.1%
- 200-day average slope (20 days)
- -7.9%
- Distance from 50-day average
- -9.1%
- Distance from 200-day average
- -31.0%
- RSI (14)
- 36.1
- Relative volume
- 0.86×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 35.5%
- Volatility vs own 5-year history
- 88th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.77
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -59.4%
- Maximum drawdown, 3 years
- -60.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 8, 2025 | Oct 2, 2026 | -60.6% | 269 days | Not yet recovered |
| Apr 20, 2022 | Jun 14, 2022 | -25.2% | 38 days | 125 days (Dec 12, 2022) |
| Oct 12, 2020 | Nov 30, 2020 | -21.0% | 34 days | 97 days (Apr 21, 2021) |
| Aug 2, 2021 | Nov 30, 2021 | -17.0% | 84 days | 97 days (Apr 20, 2022) |
| Feb 10, 2025 | Apr 4, 2025 | -15.5% | 38 days | 30 days (May 19, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $63.32B
- P/E (TTM)
- 17.3
- EPS, diluted (TTM)
- $2.46
- Revenue (TTM)
- $21.00B
- 52-week range
- $41.94 – $105.65
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $11.89B | $12.68B | $14.24B | $16.75B | $20.07B |
| Gross profit | $7.46B | $7.71B | $8.83B | $10.27B | $13.85B |
| Operating income | $1.92B | $1.82B | $2.18B | $2.63B | $3.97B |
| Net income | $1.04B | $698.0M | $1.59B | $1.85B | $2.89B |
| EPS (diluted) | $0.69 | $0.45 | $1.07 | $1.25 | $1.94 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.21B | $4.56B | $4.66B | $5.06B | $5.07B | $5.29B | $5.20B | $5.44B |
| Net income | $469.0M | $566.0M | $674.0M | $793.0M | $755.0M | $668.0M | $1.34B | $907.0M |
| EPS (diluted) | $0.32 | $0.38 | $0.45 | $0.53 | $0.50 | $0.45 | $0.90 | $0.61 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $1.87B | $1.53B | $2.50B | $3.44B | $4.53B |
| Capital expenditure | -$554.0M | -$612.0M | -$800.0M | -$790.0M | -$876.0M |
| Free cash flow | $1.32B | $914.0M | $1.70B | $2.65B | $3.66B |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $110.0M | $136.0M | $182.0M | $230.0M | $282.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $539.0M
- Total assets
- $45.22B
- Total liabilities
- $20.04B
- Total debt
- $12.62B
- Net debt
- $12.09B
- Shareholders’ equity
- $24.93B
As of Jun 30, 2026 (filed Aug 3, 2026).
Short interest
- Shares sold short
- 46,504,769
- Days to cover
- 2.35
- Change vs previous report
- -3.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 6, 2003
- 2-for-1
- Dec 1, 1998
- 2-for-1